Cefazolin in Dextrose Injection — FDA Drug Shortage

To Be Discontinued — Baxter Healthcare

The FDA lists a drug shortage record for Cefazolin in Dextrose Injection (injection) from Baxter Healthcare with status To Be Discontinued. The shortage was first posted on Oct 30, 2026.

Shortage details

Status
To Be Discontinued
Company
Baxter Healthcare
Package NDC
0338-0096-06
Dosage Form
Injection
Presentation
Cefazolin in Dextrose, Injection, 3g/150mL (NDC 0338-0096-06)
Initial Posting
Oct 30, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.